Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy?

Thomas P. Giordano, John A. Wright, Mirza Q. Hasan, A. Clinton White, Edward A. Graviss, Fehmida Visnegarwala

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

To determine whether CD4 cell count response to virus suppression during highly active antiretroviral therapy differs according to sex or race/ethnicity, we analyzed data in our observational cohort study for patients receiving their first antiretroviral regimen who experienced virus suppression by 6 months of therapy. In both univariate and multivariate analyses, women had greater CD4 cell count increases, compared with men, as did patients receiving a regimen that did not include a protease inhibitor. Race/ethnicity was not a factor.

Original languageEnglish (US)
Pages (from-to)433-437
Number of pages5
JournalClinical Infectious Diseases
Volume37
Issue number3
DOIs
StatePublished - Aug 1 2003
Externally publishedYes

Fingerprint

CD4 Lymphocyte Count
Viruses
Highly Active Antiretroviral Therapy
Protease Inhibitors
Observational Studies
Cohort Studies
Multivariate Analysis
Therapeutics

ASJC Scopus subject areas

  • Immunology

Cite this

Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy? / Giordano, Thomas P.; Wright, John A.; Hasan, Mirza Q.; White, A. Clinton; Graviss, Edward A.; Visnegarwala, Fehmida.

In: Clinical Infectious Diseases, Vol. 37, No. 3, 01.08.2003, p. 433-437.

Research output: Contribution to journalArticle

Giordano, Thomas P. ; Wright, John A. ; Hasan, Mirza Q. ; White, A. Clinton ; Graviss, Edward A. ; Visnegarwala, Fehmida. / Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy?. In: Clinical Infectious Diseases. 2003 ; Vol. 37, No. 3. pp. 433-437.
@article{d15006574f4841a8bbf5379cc42c0a68,
title = "Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy?",
abstract = "To determine whether CD4 cell count response to virus suppression during highly active antiretroviral therapy differs according to sex or race/ethnicity, we analyzed data in our observational cohort study for patients receiving their first antiretroviral regimen who experienced virus suppression by 6 months of therapy. In both univariate and multivariate analyses, women had greater CD4 cell count increases, compared with men, as did patients receiving a regimen that did not include a protease inhibitor. Race/ethnicity was not a factor.",
author = "Giordano, {Thomas P.} and Wright, {John A.} and Hasan, {Mirza Q.} and White, {A. Clinton} and Graviss, {Edward A.} and Fehmida Visnegarwala",
year = "2003",
month = "8",
day = "1",
doi = "10.1086/376638",
language = "English (US)",
volume = "37",
pages = "433--437",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy?

AU - Giordano, Thomas P.

AU - Wright, John A.

AU - Hasan, Mirza Q.

AU - White, A. Clinton

AU - Graviss, Edward A.

AU - Visnegarwala, Fehmida

PY - 2003/8/1

Y1 - 2003/8/1

N2 - To determine whether CD4 cell count response to virus suppression during highly active antiretroviral therapy differs according to sex or race/ethnicity, we analyzed data in our observational cohort study for patients receiving their first antiretroviral regimen who experienced virus suppression by 6 months of therapy. In both univariate and multivariate analyses, women had greater CD4 cell count increases, compared with men, as did patients receiving a regimen that did not include a protease inhibitor. Race/ethnicity was not a factor.

AB - To determine whether CD4 cell count response to virus suppression during highly active antiretroviral therapy differs according to sex or race/ethnicity, we analyzed data in our observational cohort study for patients receiving their first antiretroviral regimen who experienced virus suppression by 6 months of therapy. In both univariate and multivariate analyses, women had greater CD4 cell count increases, compared with men, as did patients receiving a regimen that did not include a protease inhibitor. Race/ethnicity was not a factor.

UR - http://www.scopus.com/inward/record.url?scp=0043162125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0043162125&partnerID=8YFLogxK

U2 - 10.1086/376638

DO - 10.1086/376638

M3 - Article

VL - 37

SP - 433

EP - 437

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 3

ER -